基于炎症指数的新方法在评估结肠多的新形成潜力
Sedat Ciftel1, Serpil Ciftel2, Aleksandra Klisic3,4
1Department of Gastroenterology and Hepatology, Erzurum Training and Research Hospital, 25100 Erzurum, Turkey.
Life (Basel, Switzerland)
|October 26, 2024
概括
血液学和炎症标志物,包括CALLY指数和HALP得分,可以帮助区分瘤与非瘤结直肠息肉. 这些标记物可能有助于早期检测和结直肠癌风险分层.
科学领域:
- 胃肠道学和瘤学
- 血液学和免疫学 血液学和免疫学
背景情况:
- 结肠直肠多是结肠直肠癌 (CRC) 的前体,需要准确的鉴定.
- 在患者管理和治疗决策方面,区分瘤和非瘤聚体至关重要.
研究的目的:
- 调查瘤和非瘤结直肠多之间血液学和炎症标志物的差异.
- 评估CALLY指数,HALP得分和免疫-炎症指数在区分多类型中的有用性.
主要方法:
- 对758名接受多角切除术的患者进行了回顾性横截面研究.
- 通过组织病理学将多分为瘤和非瘤类别.
- 聚组之间的CALLY指数,HALP得分和炎症指数的比较.
主要成果:
- 与非新发性息肉相比,新发性息肉的CALLY和HALP得分明显较低,免疫炎症指数较高.
- 发育不良状况,多体直径和西格体结肠位置是瘤潜力的关键因素.
- 根据近距离/远距离位置或单独/多重息肉,没有发现显著差异.
结论:
- 卡利指数,哈尔普得分和免疫-炎症指数是区分瘤与非瘤结直肠息肉的有价值标记.
- 这些标记物反映了炎症和免疫反应,有助于早期检测和风险分层.
- 这些标记物的临床整合可以提高诊断准确性和CRC风险患者的结果.
更多相关视频
06:31Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
939
09:42Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
18.6K
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
146
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
146
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
322
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
322
01:30Inflammatory Bowel Disease II: Crohn's Disease
189
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
189